Delirium in a patient with myocardial infarction
https://doi.org/10.29001/2073-8552-2022-37-3-49-55
Abstract
Delirium is a predictor of poor outcome in both myocardial infarction and other nosologies. Despite the growing interest in this problem, no effective methods for prediction, prevention, and treatment of delirium have been found. This literature review highlights the current ideas about delirium etiology, pathogenesis, approaches to prevention and treatment, and features of delirium in patients with myocardial infarction. The review presents the analysis of clinical trials and meta-analyses with the identification of causes for clinical trials failures and the search for future promising directions of research focusing on this syndrome.
About the Authors
O. O. Panteleev
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University
Russian Federation
Russian Federation
Oleg O. Panteleev, Junior Research Scientist, Department of Emergency Cardiology; Assistant Professor, Cardiology Department, Continuous Medical Education Faculty
111a, Kievskaya str., Tomsk, 634012
V. V. Ryabov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University
Russian Federation
Russian Federation
Vyacheslav V. Ryabov, Dr. Sci. (Med.), Deputy Director for Research and Clinical Services, Head of Department of Emergency Cardiology, Cardiology Research Institute; Head of Cardiology Department, Continuous Medical Education Faculty; Leading Research Scientist, Laboratory of Translational Cell and Molecular Biomedicine
111a, Kievskaya str., Tomsk, 634012
References
1. Amini M., Zayeri F., Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: Results from global burden of disease study 2017. BMC Public Health. 2021;21(1):401. DOI: 10.1186/s12889-021-10429-0.
2. Patil S., Gonuguntala K., Rojulpote C., Kumar M., Corradi J.P., Chen K. Delirium is an important predictor of mortality in elderly patients with ST-elevation myocardial infarction: Insight from National Inpatient Sample database. Coron. Artery Dis. 2020;31(8):665–670. DOI: 10.1097/MCA.0000000000000978.
3. Slooter A.J.C., Otte W.M., Devlin J.W., Arora R.C., Bleck T.P., Claassen J. et al. Updated nomenclature of delirium and acute encephalopathy: Statement of ten Societies. Intensive Care Med. 2020;46(5):1020–1022. DOI: 10.1007/s00134-019-05907-4.
4. Grover S., Ghosh A., Sarkar S., Desouza A., Yaddanapudi L.N., Basu D. Delirium in Intensive Care Unit: Phenomenology, subtypes, and factor structure of symptoms. Indian J. Psychol. Med. 2018;40(2):169–177. DOI: 10.4103/IJPSYM.IJPSYM_274_17.
5. Franco J.G., Trzepacz P.T., Sepúlveda E., Ocampo M.V., Velásquez-Tirado J.D., Zaraza D.R. et al. Delirium diagnostic tool-provisional (DDT-Pro) scores in delirium, subsyndromal delirium and no delirium. Gen. Hosp. Psychiatry. 2020;67:107–114. DOI: 10.1016/j.genhosppsych.2020.10.003.
6. Azuma K., Mishima S., Shimoyama K., Ishii Y., Ueda Y., Sakurai M. et al. Validation of the Prediction of Delirium for Intensive Care model to predict subsyndromal delirium. Acute Med. Surg. 2018;6(1):54–59. DOI: 10.1002/ams2.378.
7. Serafi m R.B., Paulino M.C., Povoa P. What every intensivist needs to know about subsyndromal delirium in the intensive care unit. Rev. Bras. Ter. Intensiva. 2020;32(1):14–16. DOI: 10.5935/0103-507x.20200004.
8. Stollings J.L., Kotfi s K., Chanques G., Pun B.T., Pandharipande P.P., Ely E.W. Delirium in critical illness: clinical manifestations, outcomes, and management. Intensive Care Med. 2021;47(10):1089–1103. DOI: 10.1007/s00134-021-06503-1.
9. Sinvani L., Delle Site C., Laumenede T., Patel V., Ardito S., Ilyas A. et al. Improving delirium detection in intensive care units: Multicomponent education and training program. J. Am. Geriatr. Soc. 2021;69(11):3249–3257. DOI: 10.1111/jgs.17419.
10. Kooken R.W.J., van den Berg M., Slooter A.J.C., Pop-Purceleanu M., van den Boogaard M. Factors associated with a persistent delirium in the intensive care unit: A retrospective cohort study. J. Crit. Care. 2021;66:132–137. DOI: 10.1016/j.jcrc.2021.09.001.
11. Wilson J.E., Mart M.F., Cunningham C., Shehabi Y., Girard T.D., MacLullich A.M.J. et al. Delirium. Nat. Rev. Dis. Primers. 2020;6(1):90. DOI: 10.1038/s41572-020-00223-4.
12. Rebenkova M.S., Gombozhapova A.E., Rogovskaya Y.V., Ryabov V.V., Kzhyshkowska Yu.G., Kim B.E. et al. Dynamics of brain CD68+ and stabilin-1+ macrophage infi ltration in patients with myocardial infarction. Kardiologiia. 2019;59(4S):44–50. (In Russ.). DOI: 10.18087/cardio.2584.
13. Kunze R., Marti H.H. Angioneurins – Key regulators of blood-brain barrier integrity during hypoxic and ischemic brain injury. Prog. Neurobiol. 2019;178:101611. DOI: 10.1016/j.pneurobio.2019.03.004.
14. Hill A.R., Spencer-Segal J.L. Glucocorticoids and the brain after critical illness. Endocrinology. 2021;162(3):bqaa242. DOI: 10.1210/endocr/bqaa242.
15. Oh J., Shin J.E., Yang K.H., Kyeong S., Lee W.S., Chung T.S. et al. Cortical and subcortical changes in resting-state functional connectivity before and during an episode of postoperative delirium. Aust. N. Z. J. Psychiatry. 2019;53(8):794–806. DOI: 10.1177/0004867419848826.
16. Ibrahim K., McCarthy C.P., McCarthy K.J., Brown C.H., Needham D.M., Januzzi J.L. Jr. et al. Delirium in the Cardiac Intensive Care Unit. J. Am. Heart Assoc. 2018;7(4):e008568. DOI: 10.1161/JAHA.118.008568.
17. Kirfel A., Menzenbach J., Guttenthaler V., Feggeler J., Mayr A., Coburn M. et al. Postoperative delirium after cardiac surgery of elderly patients as an independent risk factor for prolonged length of stay in intensive care unit and in hospital. Aging Clin. Exp. Res. 2021;33(11):3047–3056. DOI: 10.1007/s40520-021-01842-x.
18. Cha S., Brown C.H. Treating delirium in the intensive care unit: No easy answers. J. Thorac. Cardiovasc. Surg. 2020;159(5):1895–1898. DOI: 10.1016/j.jtcvs.2019.02.143.
19. Jäckel M., Zotzmann V., Wengenmayer T., Duerschmied D., Biever P.M., Spieler D. et al. Incidence and predictors of delirium on the intensive care unit after acute myocardial infarction, insight from a retrospective registry. Catheter. Cardiovasc. Interv. 2021;98(6):1072–1081. DOI: 10.1002/ccd.29275.
20. Holland E.M., Moss T.J. Acute noncardiovascular illness in the Cardiac Intensive Care Unit. J. Am. Coll. Cardiol. 2017;69(16):1999–2007. DOI: 10.1016/j.jacc.2017.02.033.
21. Grotti S., Falsini G. Delirium in cardiac patients. Eur. Heart J. 2017;38(29):2244. DOI: 10.1093/eurheartj/ehx380.
22. Thomas C., Spank J., Weller S., Eschweiler G.W. Nonpharmaceutical concepts for prevention and treatment of delirium. Z. Gerontol. Geriatr. 2021;54(8):759–767. (In Germ.). DOI: 10.1007/s00391-021-01988-3.
23. Oh E.S., Fong T.G., Hshieh T.T., Inouye S.K. Delirium in older persons: Advances in diagnosis and treatment. JAMA. 2017;318(12):1161–1174. DOI: 10.1001/jama.2017.12067.
24. Woodhouse R., Burton J.K., Rana N., Pang Y.L., Lister J.E., Siddiqi N. Interventions for preventing delirium in older people in institutional longterm care. Cochrane Database Syst. Rev. 2019;4(4):CD009537. DOI: 10.1002/14651858.CD009537.pub3.
25. Fukata S., Kawabata Y., Fujishiro K., Kitagawa Y., Kuroiwa K., Akiyama H. et al. Haloperidol prophylaxis for preventing aggravation of postoperative delirium in elderly patients: A randomized, open-label prospective trial. Surg. Today. 2017;47(7):815–826. DOI: 10.1007/s00595-016-1441-2.
26. Hollinger A., Rüst C.A., Riegger H., Gysi B., Tran F., Brügger J. et al. Ketamine vs. haloperidol for prevention of cognitive dysfunction and postoperative delirium: A phase IV multicentre randomised placebo-controlled double-blind clinical trial. J. Clin. Anesth. 2021;68:110099. DOI: 10.1016/j.jclinane.2020.110099.
27. Van den Boogaard M., Slooter A.J.C., Brüggemann R.J.M., Schoonhoven L., Beishuizen A., Vermeijden J.W. et al. Eff ect of haloperidol on survival among critically ill adults with a high risk of delirium: The REDUCE Randomized Clinical Trial. JAMA. 2018;319(7):680–690. DOI: 10.1001/jama.2018.0160.
28. Lin P., Zhang J., Shi F., Liang Z.A. Can haloperidol prophylaxis reduce the incidence of delirium in critically ill patients in intensive care units? A systematic review and meta-analysis. Heart Lung. 2020;49(3):265–272. DOI: 10.1016/j.hrtlng.2020.01.010.
29. Walker C.K., Gales M.A. Melatonin receptor agonists for delirium prevention. Ann. Pharmacother. 2017;51(1):72–78. DOI: 10.1177/1060028016665863.
30. Ng K.T., Teoh W.Y., Khor A.J. The eff ect of melatonin on delirium in hospitalised patients: A systematic review and meta-analyses with trial sequential analysis. J. Clin. Anesth. 2020;59:74–81. DOI: 10.1016/j.jclinane.2019.06.027.
31. Витик А.А., Шень Н.П. Органопротекторные свойства агониста α2-а-дренорецепторов дексмедетомидина (обзор литературы). Вестник интенсивной терапии имени А.И. Салтанова. 2018;4:74–79. Vitik A.A., Shen N.P. Organoprotective eff ects of the α2-adrenoreceptor agonist dexmedetomidine (literature review). Alexander Saltanov Intensive Care Herald. 2018;4:74–79. (In Russ.).
32. Skrobik Y., Duprey M.S., Hill N.S., Devlin J.W. Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled Trial. Am. J. Respir. Crit. Care Med. 2018;197(9):1147–1156. DOI: 10.1164/rccm.201710-1995OC.
33. Xu X.Q., Luo J.Z., Li X.Y., Tang H.Q., Lu W.H. Eff ects of perioperative rosuvastatin on postoperative delirium in elderly patients: A randomized, double-blind, and placebo-controlled trial. World. J. Clin. Cases. 2021;9(21):5909–5920. DOI: 10.12998/wjcc.v9.i21.5909.
34. Naef A.C., Jeitziner M.M., Gerber S.M., Jenni-Moser B., Müri R.M., Jakob S.M. et al. Virtual reality stimulation to reduce the incidence of delirium in critically ill patients: Study protocol for a randomized clinical trial. Trials. 2021;22(1):174. DOI: 10.1186/s13063-021-05090-2.
35. Cortés-Beringola A., Vicent L., Martín-Asenjo R., Puerto E., Domínguez-Pérez L., Maruri R. et al. Diagnosis, prevention, and management of delirium in the intensive cardiac care unit. Am. Heart J. 2021;232:164–176. DOI: 10.1016/j.ahj.2020.11.011.
36. Kohler J., Borchers F., Endres M., Weiss B., Spies C., Emmrich J.V. Cognitive deficits following intensive care. Dtsch. Arztebl. Int. 2019;116(38):627–634. DOI: 10.3238/arztebl.2019.0627.
37. Shivji S., Stabler S.N., Boyce K., Haljan G.J., McGloin R. Management of delirium in a medical and surgical intensive care unit. J. Clin. Pharm. Ther. 2021;46(3):669–676. DOI: 10.1111/jcpt.13319.
38. Hui D., Frisbee-Hume S., Wilson A., Dibaj S.S., Nguyen T., De La Cruz M. et al. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial. JAMA. 2017;318(11):1047–1056. DOI: 10.1001/jama.2017.11468.
39. Devlin J.W., Roberts R.J., Fong J.J., Skrobik Y., Riker R.R., Hill N.S. et al. Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit. Care Med. 2010;38(2):419–427. DOI: 10.1097/CCM.0b013e3181b9e302.
40. Boettger S., Friedlander M., Breitbart W., Passik S. Aripiprazole and haloperidol in the treatment of delirium. Aust. N. Z. J. Psychiatry. 2011;45(6):477–482. DOI: 10.3109/00048674.2011.543411.
41. Wang S., Hong Y., Li S., Kuriyama A., Zhao Y., Hu J. et al. Effect of dexmedetomidine on delirium during sedation in adult patients in intensive care units: A systematic review and meta-analysis. J. Clin. Anesth. 2021;69:110157. DOI: 10.1016/j.jclinane.2020.110157.
Review
For citations:
Panteleev O.O., Ryabov V.V. Delirium in a patient with myocardial infarction. Siberian Journal of Clinical and Experimental Medicine. 2022;37(3):49-55. (In Russ.) https://doi.org/10.29001/2073-8552-2022-37-3-49-55
Views:
560
.png)
Email this article 